AdvaMed® Statement on Participation in HHS Vaccine Consultation Panel
WASHINGTON, D.C. – Today AdvaMed® President and CEO Scott Whitaker released the following statement about AdvaMed®’s participation on the HHS Vaccine Consultation Panel.
AdvaMed® Praises Expanded Coverage of FDA-Designated “Breakthrough” Medical Technologies for Medicare Beneficiaries
WASHINGTON, D.C. – Today, AdvaMed® President and CEO Scott Whitaker commended CMS on the rule the agency released today establishing a new coverage pathway – MCIT – for breakthrough medical technologies:
AdvaMed® Selects DeChane Dorsey as Executive Director for AdvaMed Accel®
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today named DeChane Dorsey the new Executive Director of AdvaMed Accel®, the division within AdvaMed® dedicated to the needs of small and start-up…
AdvaMed® Praises Gov. Newsom’s Budget Proposal to Expand Coverage of Continuous Glucose Monitors for Diabetes Patients
WASHINGTON, D.C. – In a statement today from AdvaMed® President and CEO Scott Whitaker, the world’s largest trade association representing medical technology companies and manufacturers praised California Gov. Gavin Newsom for…
AdvaMed® Statement on Today’s Violence at the U.S. Capitol
WASHINGTON, D.C. – On behalf of AdvaMed®, the world’s largest trade association representing medical technology companies, President and CEO Scott Whitaker released the following statement:
The Medtech Conference Wins Top Honors at IAEE 2020 Art of the Show Competition
Washington, D.C. — The Medtech Conference won several International Association of Exhibitions and Events (IAEE) Art of the Show Competition awards, including Best Email Promotion Campaign, Best Show Promotion Website, and tied for the prestigious…
AdvaMed® Praises U.S.-Ecuador Trade Package
The Advanced Medical Technology Association® (AdvaMed®) today issued the following statement from President and CEO Scott Whitaker on the newly concluded United States-Ecuador Trade Package announced today.
“Big Milestone”: Medtech Industry Has Shipped More Than 255 Million Molecular COVID-19 Tests Nationwide
WASHINGTON, D.C. – New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry shows that total U.S. shipments of COVID-19 molecular diagnostic tests have topped more than 255 million since the beginning of…
AdvaMed® Issues Medtech Industry Principles to Address Racial Health Disparities
Washington, D.C – Today the Advanced Medical Technology Association® (AdvaMed®), under the leadership of the Board of Directors, issued a set of principles to guide the industry in addressing racial health disparities.
AdvaMed® Welcomes Vision 2025 Roadmap to Reinforce Business Integrity Across APEC Region Amidst COVID-19
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) this week joined medtech industry, government and other health care stakeholders at the Asia-Pacific Economic Cooperation (APEC) Business Ethics for Small- and Medium-Sized…